626 related articles for article (PubMed ID: 33715271)
1. Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
Chebly A; Ropio J; Peloponese JM; Poglio S; Prochazkova-Carlotti M; Cherrier F; Ferrer J; Idrissi Y; Segal-Bendirdjian E; Chouery E; Farra C; Pham-Ledard A; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Mol Oncol; 2022 May; 16(9):1931-1946. PubMed ID: 33715271
[TBL] [Abstract][Full Text] [Related]
2. Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.
Chebly A; Prochazkova-Carlotti M; Idrissi Y; Bresson-Bepoldin L; Poglio S; Farra C; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Front Oncol; 2021; 11():775253. PubMed ID: 34765562
[TBL] [Abstract][Full Text] [Related]
3. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Apolónio JD; Dias JS; Fernandes MT; Komosa M; Lipman T; Zhang CH; Leão R; Lee D; Nunes NM; Maia AT; Morera JL; Vicioso L; Tabori U; Castelo-Branco P
Clin Epigenetics; 2022 Dec; 14(1):178. PubMed ID: 36529814
[TBL] [Abstract][Full Text] [Related]
4. Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
Garsuault D; Bouyer C; Nguyen E; Kandhari R; Prochazkova-Carlotti M; Chevret E; Forgez P; Ségal-Bendirdjian E
Mol Oncol; 2020 Jun; 14(6):1310-1326. PubMed ID: 32239597
[TBL] [Abstract][Full Text] [Related]
5. Spotlight on
Ropio J; Prochazkova-Carlotti M; Batista R; Pestana A; Chebly A; Ferrer J; Idrissi Y; Cappellen D; Durães C; Boaventura P; Vinagre J; Azzi-Martin L; Poglio S; Cabeçadas J; Campos MA; Beylot-Barry M; Sobrinho-Simões M; Merlio JP; Soares P; Chevret E
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833366
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
[TBL] [Abstract][Full Text] [Related]
9. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
[TBL] [Abstract][Full Text] [Related]
10. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
[TBL] [Abstract][Full Text] [Related]
11. Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Li CT; Hsiao YM; Wu TC; Lin YW; Yeh KT; Ko JL
J Cell Biochem; 2011 Oct; 112(10):3044-53. PubMed ID: 21678477
[TBL] [Abstract][Full Text] [Related]
12. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Bechter OE; Eisterer W; Dlaska M; Kühr T; Thaler J
Exp Hematol; 2002 Jan; 30(1):26-33. PubMed ID: 11823034
[TBL] [Abstract][Full Text] [Related]
13. The correlation between CpG island methylation of hTERT promoter and human age prediction.
Cui H; Xin Y; Cao F; Gan Z; Tian Y; Liu W; Shi P
Leg Med (Tokyo); 2023 Jul; 63():102270. PubMed ID: 37207612
[TBL] [Abstract][Full Text] [Related]
14. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
Guilleret I; Benhattar J
Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
Rowland TJ; Bonham AJ; Cech TR
Mol Oncol; 2020 Oct; 14(10):2358-2374. PubMed ID: 33245585
[TBL] [Abstract][Full Text] [Related]
17. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
[TBL] [Abstract][Full Text] [Related]
18. Differential DNA Methylation of THOR and
Ott P; Araúzo-Bravo MJ; Hoffmann MJ; Poyet C; Bendhack ML; Santourlidis S; Erichsen L
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139544
[TBL] [Abstract][Full Text] [Related]
19. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.
Lopatina NG; Poole JC; Saldanha SN; Hansen NJ; Key JS; Pita MA; Andrews LG; Tollefsbol TO
Biochem Biophys Res Commun; 2003 Jul; 306(3):650-9. PubMed ID: 12810068
[TBL] [Abstract][Full Text] [Related]
20. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]